Episode 16-Special | 2026/05/04

【ENT Update 特輯】2026年頭頸部腫瘤10大重要文獻回顧 本集探討以下10篇2026年關鍵文獻： 1. Neoadjuvant Chemoimmunotherapy Meta-analysis. Baratz HQ et al. JAMA Otolaryngol Head Neck Surg 2026. doi:10.1001/jamaoto.2026.0080 2. LEAP-010: Pembrolizumab ± Lenvatinib in R/M HNSCC. Licitra L et al. J Clin Oncol 2026. doi:10.1200/JCO-25-00570 3. ctDNA-MRD in HPV-independent HNSCC. Ruiz-Torres DA et al. JAMA Otolaryngol Head Neck Surg 2026. doi:10.1001/jamaoto.2025.4837 4. Predictive Biomarkers for Immunotherapy in HNSCC. Expert Rev Clin Pharmacol 2026. doi:10.1080/17512433.2026.2665455 5. NeoLOCUS: Low-dose Nivolumab in Borderline Resectable OSCC. Marimuthu PK et al. Lancet Reg Health SE Asia 2026. doi:10.1016/j.lansea.2026.100743 6. Medial RPN-Sparing RT in NPC. Wang SX et al. BMJ 2026. doi:10.1136/bmj-2025-086050 7. CAYA NPC Multimodality Therapy. Ren M et al. Front Immunol 2026. doi:10.3389/fimmu.2026.1765851 8. CAPTAIN-1st 5-Year: Camrelizumab in R/M NPC. JAMA Oncol 2026. doi:10.1001/jamaoncol.2025.6245 9. EBV-HLA Interactions in NPC Risk. Nature 2026. doi:10.1038/s41586-026-10416-8 10. Decisional Conflict in Palliative HNC. van den Besselaar BN et al. Otolaryngol Head Neck Surg 2026. doi:10.1002/ohn.70256 「ENT Update」— 每週專業耳鼻喉頭頸外科深度對談